Immunocore files to sell 25,000 ADRs under Rule 144

Immunocore Holdings Plc submitted a Rule 144 notice to sell 25,000 ADRs.

Accepted by SEC EDGAR 04/08/2026 - 03:57 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Immunocore Holdings Plc submitted a Rule 144 notice to sell 25,000 ADRs. The filing lists a planned sale method as a "Same Day Cashless Exercise and Sale" with a trade date of 04/08/2026 and settlement or delivery date of 04/09/2026. The excerpt also reports two prior ADR dispositions by David Berman totaling 17,797 ADRs on 02/18/2026 and 03/11/2026 with proceeds shown.

Key Figures

Planned sale: 25,000 ADRs Settlement/delivery date: 04/09/2026 Prior disposition 1: 5,965 ADRs +2 more

5 metrics

Planned sale 25,000 ADRs Same Day Cashless Exercise and Sale; trade date 04/08/2026

Settlement/delivery date 04/09/2026 Delivery date shown for the planned sale

Prior disposition 1 5,965 ADRs Sold 02/18/2026 by David Berman for $192,951.05

Prior disposition 2 11,832 ADRs Sold 03/11/2026 by David Berman for $385,330.11

Placement agent / broker J.P. Morgan Securities LLC Broker/dealer listed on the excerpt (address shown)

Key Terms

ADR, Same Day Cashless Exercise and Sale, Rule 144

3 terms

ADR financial

"ADR | J.P. Morgan Securities LLC 270 Park Ave 10th Floor New"

An American Depositary Receipt (ADR) is a financial certificate that lets investors buy shares of a foreign company through U.S. stock markets, similar to buying a local wrapper that represents the underlying foreign shares. ADRs matter because they make investing in overseas companies easier and more liquid by trading in U.S. dollars and under U.S. market rules, while still carrying currency, regulatory, and country-specific risks that can affect share value.

Same Day Cashless Exercise and Sale financial

"Same Day Cashless Exercise and Sale | Immunocore Holdings Plc (issuer)"

Rule 144 regulatory

"Filer Information | 144: Filer Information"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Immunocore (IMCR) Rule 144 filing mean?

It notifies the market of a proposed resale of restricted or control securities under Rule 144. The filing lists a proposed sale of 25,000 ADRs via a same‑day cashless exercise and sale on 04/08/2026.

Who is the selling party in the IMCR Form 144 excerpt?

The excerpt identifies transactions by David Berman; prior dispositions shown are 5,965 ADRs (02/18/2026) and 11,832 ADRs (03/11/2026). The proposed 25,000 ADR sale is listed separately.

How was the planned sale to be executed for IMCR ADRs?

The planned method is described as a "Same Day Cashless Exercise and Sale", indicating an exercise and simultaneous sale mechanism reported with trade date 04/08/2026.

What proceeds are shown from recent ADR dispositions in the excerpt?

The filing shows proceeds of $192,951.05 for 5,965 ADRs (02/18/2026) and $385,330.11 for 11,832 ADRs (03/11/2026), as reported in the excerpt.

Does this Rule 144 filing state who receives the sale proceeds?

The excerpt identifies the selling holder and cash consideration figures for prior dispositions, but it does not assign proceeds recipients beyond those seller entries shown in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001955244
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Immunocure Holdings PLC
SEC File Number
Address of Issuer	181 Washington St Suite 200 Conshohocken PENNSYLVANIA 19428
Phone	441235438600
Name of Person for Whose Account the Securities are To Be Sold	David Berman
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ADR	J.P. Morgan Securities LLC 270 Park Ave 10th Floor New York NY 10017	25000	796250	50387068	04/08/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ADR	04/08/2026	Same Day Cashless Exercise and Sale	Immunocore Holdings Plc (issuer)			25000	04/09/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Berman 4915 Hampden Ln Unit 405 Bethesda MD 20814	ADR	02/18/2026	5965	192951.05
David Berman 4915 Hampden Ln Unit 405 Bethesda MD 20814	ADR	03/11/2026	11832	385330.11

144: Remarks and Signature

Remarks
Date of Notice	04/08/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	J.P. Morgan Securities LLC, Workplace Solutions, as Agent and Attorney in Fact for David Berman, Immunocore Holdings PLC
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)